Professional Documents
Culture Documents
GENETIC DISORDERS
A. Etiology
- all are a result of a mutation in the genetic code
1. Point Mutation
- change of a single base-pair of a gene → incorporation of incorrect amino acid →
functional change in the product protein (ex: thalassemia)
2. Frameshift Mutation
3. Recombination Event Errors
- gross rearrangement of the gene/errors in chromosome movement (ex: chronic
myeloid leukaemia)
B. Types
1. Congenital
- inherited at birth
2. Somatic
- arise during a person’s life
- responsible for the collective disease known as cancer
- gross chromosomal and point mutations occur in somatic genetic disease
C. Major Categories
1. Single Gene (Monogenic) or Mendelian Defects
2. Multifactorial Disorders
3. Chromosomal Disorders
4. Somatic Cell Gene Defects
5. Mitochondrial Mutations
For Your Eyes Only
GENE DEFECTS
A. Mendelian and Sex-Linked Single-Gene Disorders
- result of mutations in coding sequences and their control elements → various effects on gene
expression → dysfunction of protein product
B. Mutations
1. Point mutation
- simplest type of change
- involves substitution of one nucleotide for another → changed codon in a coding sequence
a. Thalassemia
- different amino acids are incorporated into the polypeptide chain
2. Insertion or Deletion
- more serious change → alteration of the rest of the following sequence → frame-shift
mutation
a. Duchenne Muscular Dystrophy
- large deletions in the dystrophin gene
b. Insertion/Deletion (ID) Polymorphism in the Angiotensin-Converting Enzyme (ACE)
Gene
- deletion of 287 bp repeat sequence
- result in the genotypes II (ID and DD)
- DD - associated with
- higher concentrations of circulating ACE
- possibly cardiac disease
3. Splicing Mutations
- mutation of DNA sequences which direct the splicing of introns → abnormal splicing →
mRNA may carry intron sequences → translation → altered polypeptide chain
4. Termination Mutations
a. Normal Polypeptide Chain Termination
- when the ribosomes processing the mRNA reach one of the chain termination or “stop”
codons
For Your Eyes Only
b. Termination Mutations
→ late or premature termination
- ex: Haemoglobin Constant Spring
- hemoglobin variant
- instead of “stop” sequence → single base change → insertion of extra amino
acid
c. X-Linked
a. Occurrence
- occurs when one of the two copies has a mutation and the protein product of the
normal form of the gene cannot compensate
- a heterozygous individual who has two different forms (or alleles) of the same
gene → manifest the disease
- offspring of heterozygotes → 50% chance of inheriting the chromosome
carrying the disease allele → disease
- affected persons may be of both sexes
- appear in most generations
For Your Eyes Only
b. Estimation of Risk to Offspring
i. Recurrence Risk for the Mating of an Affected Individual (Aa) with a
Homozygous Unaffected Individual (aa)
iiia. Achondroplasia
- most cases are due to new mutations
d. Overall Incidence
- 7 per 1000 live births
For Your Eyes Only
e. Huntington Disease
- autosomal dominant
- 1 in 20,000
- manifestations
- progressive dementia
- loss of motor control
- affective disorder
- trinucleotide repeat expansion disorder
- buildup of toxic protein in neurons results in neuronal death
f. Marfan Syndrome
- autosomal dominant
- 1 in 10,000
- mutation in fibrillin gene
- manifestations
- thin
- elongated limbs
- hypermobile joints
- frequent myopia
- mitral valve prolapse
- aortic aneurysm
For Your Eyes Only
6. Autosomal Recessive Disorders
- manifest only when an individual is homozygous for the disease allele (both chromosomes
carry the mutated gene)
- affected persons are of both sexes
- appear sporadically and infrequently throughout a family tree
- typically seen in only one generation of a pedigree
- males and females are affected in roughly equal frequencies
a. Family History
- parents are generally unaffected healthy carriers (heterozygous for the disease allele)
- usually no family history
- defective gene is passed from generation to generation
b. Offspring of an Affected Person
- healthy heterozygotes unless the other parent is also a carrier
i. Recurrence Risk for the Mating of Two Heterozygous Carriers (Aa) of Recessive
Mutation
c. Carriers
- if marries → offspring have
- 1 in 4 chance of being homozygous and affected
- 1 in 2 chance of being a carrier
- 1 in 4 chance of being genetically normal
For Your Eyes Only
d. Consanguinity
- increases the risk
e. Clinical Features
- usually severe
- often present in the first few years of life
- high mortality
f. Overall Incidence
- about 2.5 per 1000 live births
7. Sex-Linked Disorders
a. Genes on the X Chromosome
- said to be “X-linked”
- can be dominant or recessive
i. Females
- have two X chromosomes → unaffected carriers of X-linked recessive
diseases
For Your Eyes Only
ii. Males
- have just one X chromosome → any deleterious mutation in X-linked gene →
manifests because no second copy of the gene is present
b. X-Linked Dominant Disorders
- rare
i. Who Will Manifest the Disease
- females who are heterozygous for the mutant gene
- males who have one copy of the mutant gene on their single X chromosome
- half the male or female offspring of an affected mother
- all the female offspring of an affected man will have the disease
ii. Affected Males
- has only one X chromosome → always passes the disease to daughters
- tend to have the disease more severely than the heterozygous female
Affected Male
X Y
x Xx xY
x Xx xY
Normal Female
Normal Male
x Y
X Xx XY
x xx xY
Affected Female
For Your Eyes Only
iv. Example Diseases
iva. Hypophosphatemic Rickets
ivb. Fragile X Syndrome
ivbi. Males
- 100% penetrance
- mental retardation
- large ears
- prominent jaw
- macro-orchidism (usually postpubertal)
ivbii. Females
- 60% penetrance
- mental retardation
c. X-Linked Recessive Disorders
ii. Transmission
- by - healthy female carriers
- affected males if they survive to reproduce
- male-to-male transmission is not seen
iii. Recurrence Risks for X-linked Recessive Diseases
Affected Male
x Y
X Xx XY
X Xx XY
Normal Female
Normal Male
X Y
X XX XY
x Xx xY
Carrier Female
iv. Hemophilia A
iva. Defect
- mutation in the X-linked gene for factor VIII
- intrachromosomal rearrangement (inversion) of the tip of the long
arm of the X chromosome (one break point being within
intron 22 of the factor VIII gene) in 50% of cases
ivb. Offspring from a Carrier Female and a Normal Male
- 50% of the girls → inherit a mutant allele from their mother and the
normal allele from their father → carriers
- 50% of the girls → inherit two normal alleles → normal
- 50% of the boys → inherit the mutant allele from their mother (and
the Y chromosome from their father) → hemophilia
- 50% of the boys → inherit the normal allele from their mother (and
the Y chromosome from their father) → normal
ivc. Male Offspring of a Male with Hemophilia and a Normal Female
- do not inherit his X chromosome → will not have the disease
For Your Eyes Only
ivd. All Female Offspring of a Male with Hemophilia and a Normal Female
- inherit his X chromosome → carriers
v. Other Example Diseases
- Duchenne muscular dystrophy
- Lesch-Nyhan syndrome (hypoxanthine-guanine phosphoribosyltransferase
[HGPRT] deficiency)
- glucose-6-phosphate dehydrogenase deficiency
- hemophilia A and B
- red-green color blindness
- Menke’s disease
- ornithine transcarbamoylase (OTC) deficiency
- SCID (IL-receptor γ-chain deficiency)
For Your Eyes Only
d. Incomplete Penetrance
- some individuals who have the disease genotype do not display disease phenotype
- “degree of penetrance” is the proportion of obligate carriers who display the
disease phenotype
- these are diseases in which a secondary event is required to cause expression
b. Mitochondrial Diseases
- various mitochondrial gene mutations → complex disease syndromes with incomplete
penetrance maternal inheritance
i. Mitochondria
- carry their own DNA
- inherited from the mother (only the oocyte contributes mitochondria to the
zygote; the sperm neck and tail, which carry mitochondria of the sperm,
never penetrate the oocyte)
ii. Maternal Mitochondria Mutation
- any mutation → passed to offspring
- heterogenous mitochondrial DNA → often a defect in one or many
mitochondria can be compensated for by others → not all mutations
cause disease
GENE TESTING
A. Genetic Tests
- direct examination of the DNA molecule
- biochemical tests for the gene products
- chromosomal analysis
B. Reasons for Genetic Testing
- carrier screening
- identifying unaffected individuals who carry one copy of a gene for a disease that requires two
copies in order for the disease to be expressed
- preimplantation genetic diagnosis (screening embryos for disease)
- prenatal diagnostic testing
- newborn screening
- presymptomatic testing
- predicting adult-onset disorders such as Huntington’s disease
- estimating the risk of developing adult-onset cancers and Alzheimer’s disease
- confirmational diagnosis of a symptomatic individual
- forensic/identity testing
C. DNA Probes
- sequences are complementary to the mutated sequences
1. Uses - examine an individual’s genome
- make comparisons of the sequence of DNA bases in one of their genes with a normal version of
that gene
D. Some Examples of Diseases Detected by Genetic Testing
- alpha-1-antitrypsin deficiency (emphysema and liver disease)
- amyotrophic lateral sclerosis (Lou Gehrig’s disease, progressive motor function loss)
- Alzheimer’s disease (APOE, late-onset variety of senile dementia)
- Gaucher’s disease (enlarged liver and spleen, bone degeneration)
- inherited breast and ovarian cancer (BRCA 1 and 2, early-onset tumours)
- congenital adrenal hyperplasia (hormone deficiency, ambiguous genitalia)
- cystic fibrosis (disease of lung and pancreas)
- Duchenne muscular dystrophy/Becker muscular dystrophy (severe to mild muscle wasting,
deterioration, weakness)
- dystonia (muscle rigidity, repetitive twisting movements)
- factor V-Leiden (blood-clotting disorder)
- fragile X syndrome (leading cause of inherited mental retardation)
- galactosemia (metabolic disorder affects ability to metabolise galactose)
- haemophilia A and B (bleeding disorders)
- hereditary hemochromatosis (excess iron storage disorder)
- Huntington’s disease (progressive, lethal, degenerative neurological disease)
- Marfan syndrome (connective tissue disorder)
- mucopolysaccharidosis (deficiency of enzymes in breaking down glycosaminoglycans)
- myotonic dystrophy (progressive muscle weakness, adult muscular dystrophy)
- phenylketonuria (missing enzyme, phenylalanine hydroxylase, correctable by diet)
For Your Eyes Only
- sickle cell disease (blood-cell disorder)
- spinal muscular atrophy (severe, usually lethal, progressive muscle-wasting disorder)
- Tay-Sachs disease (fatal neurological disease of early childhood)
- thalassemias (anemias)
E. Advantages and Disadvantages of Gene Testing
1. Advantages
- clarify a diagnosis
- allow families to avoid having children with devastating diseases
- identify people at high risk for conditions that may be preventable
2. Disadvantages
- gene tests are targeted to healthy, presymptomatic individuals who are identified as being at high
risk because of a strong family medical history for the disorder
- give only a probability for developing the disorder
- difficulty in interpreting a positive result because some people who carry a disease-associated
mutation may never develop the disease
- implications for family members since genetic information is shared
- uncertainties surrounding test interpretation
- current lack of available medical options for some diseases
- potential for provoking anxiety
- risks for discrimination and social stigmatisation